VJHemOnc is committed to improving our service to you

ASH 2019 | CLL: relapsed disease, discontinuation and MRD

VJHemOnc is committed to improving our service to you

Barbara Eichhorst

Barbara Eichhorst, MD, University of Cologne, Cologne, Germany, discusses relapsed disease, treatment discontinuation and MRD in chronic lymphocytic leukemia (CLL), highlighting observations from the MURANO trial (NCT02005471). This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter